Search Results - "Theißen, Jessica"
-
1
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
Published in Nature (London) (14-07-2016)“…Poor prognosis in neuroblastoma is associated with genetic amplification of MYCN . MYCN is itself a target of let-7 , a tumour suppressor family of microRNAs…”
Get full text
Journal Article -
2
Mutational dynamics between primary and relapse neuroblastomas
Published in Nature genetics (01-08-2015)“…Alexander Schramm, Johannes Schulte and colleagues characterize 16 paired samples from patients with neuroblastoma at diagnosis and relapse using whole-exome…”
Get full text
Journal Article -
3
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
Published in JNCI : Journal of the National Cancer Institute (01-10-2018)“…Neuroblastoma is characterized by substantial clinical heterogeneity. Despite intensive treatment, the survival rates of high-risk neuroblastoma patients are…”
Get full text
Journal Article -
4
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
Published in Clinical cancer research (15-04-2015)“…To optimize neuroblastoma treatment stratification, we aimed at developing a novel risk estimation system by integrating gene expression-based classification…”
Get full text
Journal Article -
5
FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Published in BMC cancer (18-11-2014)“…Segmental genomic copy number alterations, such as loss of 11q or 3p and gain of 17q, are well established markers of poor outcome in neuroblastoma, and have…”
Get full text
Journal Article -
6
High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
Published in Clinical cancer research (01-08-2011)“…Genomic alterations of the anaplastic lymphoma kinase (ALK) gene have been postulated to contribute to neuroblastoma pathogenesis. This study aimed to…”
Get full text
Journal Article -
7
Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma
Published in International journal of cancer (01-10-2012)“…About 50% of children with neuroblastoma (NB) show a metastatic disease and have a poor prognosis. However, disease progression is greatly variable and depends…”
Get full text
Journal Article -
8
Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
Published in Journal of clinical oncology (20-07-2010)“…To evaluate the impact of a predefined gene expression-based classifier for clinical risk estimation and cytotoxic treatment decision making in neuroblastoma…”
Get full text
Journal Article -
9
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma
Published in Genes chromosomes & cancer (01-08-2014)“…The prognostic relevance of chromosome 17 gain in neuroblastoma is still discussed. This investigation specifies the frequency, type, size, and transcriptional…”
Get full text
Journal Article -
10
A method for finding consensus breakpoints in the cancer genome from copy number data
Published in Bioinformatics (15-07-2013)“…Recurrent DNA breakpoints in cancer genomes indicate the presence of critical functional elements for tumor development. Identifying them can help determine…”
Get full text
Journal Article -
11
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma
Published in Nature genetics (01-04-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
12
High Genomic Instability Predicts Survival in Metastatic High-Risk Neuroblastoma
Published in Neoplasia (New York, N.Y.) (01-09-2012)“…Abstract We aimed to identify novel molecular prognostic markers to better predict relapse risk estimate for children with high-risk (HR) metastatic…”
Get full text
Journal Article -
13
Heterogeneity of the MYCN Oncogene in Neuroblastoma
Published in Clinical cancer research (15-03-2009)“…Purpose: MYCN amplification is an important therapy-stratifying marker in neuroblastoma. Fluorescence in situ hybridization with signal detection on the…”
Get full text
Journal Article -
14
FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma
Published in BMC cancer (18-11-2014)Get full text
Journal Article -
15
Molecular characterization and classification of neuroblastoma
Published in Future oncology (London, England) (01-06-2009)“…For many decades, neuroblastoma has remained a challenging disease for both clinicians and researchers. Now, techniques that efficiently specify both…”
Get more information
Journal Article -
16
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma
Published in Nature genetics (01-01-2020)“…Extrachromosomal circularization of DNA is an important genomic feature in cancer. However, the structure, composition and genome-wide frequency of…”
Get full text
Journal Article -
17
Genomic ALK alterations in primary and relapsed neuroblastoma
Published in British journal of cancer (12-04-2023)“…Background Genomic alterations of the anaplastic lymphoma kinase gene ( ALK ) occur recurrently in neuroblastoma, a pediatric malignancy of the sympathetic…”
Get full text
Journal Article -
18
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
Published in Genome Biology (25-06-2015)“…Gene expression profiling is being widely applied in cancer research to identify biomarkers for clinical endpoint prediction. Since RNA-seq provides a powerful…”
Get full text
Journal Article -
19
Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome
Published in Journal of pediatric hematology/oncology (01-03-2018)“…Opsoclonus myoclonus syndrome (OMS), often called "dancing eyed syndrome," is a rare neurological condition associated with neuroblastoma in the majority of…”
Get full text
Journal Article -
20
Abstract LB-290: Multiple distinct mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Abstract The let-7 microRNA family are known tumor suppressors often deregulated in cancer, yet the underlying mechanisms of let-7 disruption remain poorly…”
Get full text
Journal Article